Rho-associated kinase inhibitor enhances the culture condition of isolated mouse salivary gland cells in vitro
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Choongseong | - |
dc.contributor.author | An, Geun Ho | - |
dc.contributor.author | Woo, Dong-Hun | - |
dc.contributor.author | Kim, Jong-Hoon | - |
dc.contributor.author | Park, Hee-Kyung | - |
dc.date.accessioned | 2021-09-02T06:08:33Z | - |
dc.date.available | 2021-09-02T06:08:33Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-10 | - |
dc.identifier.issn | 0040-8166 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/73009 | - |
dc.description.abstract | Hyposalivation because of curative radiation therapy in patients with head and neck cancer is a major concern. At present, there is no effective treatment for hyposalivation, highlighting the importance of cell therapy as a new therapeutic approach. To provide functional cells for cell replacement therapy, it is important to overcome the limitations of current in vitro culture methods for isolated salivary gland cells. Here, we suggest an improved culture condition method for the cultivation of isolated salivary gland cells. The dissociated submandibular salivary gland cells of mice were seeded and treated with Rho-associated kinase (ROCK) inhibitor (Y-27632), which resulted in an increase in their cell adhesion, viability, migration, and proliferation. In particular, ROCK inhibitor treatment maintained the expression of alpha-amylase in the primary cultured salivary gland cells for a long time as compared with untreated cells. The expression of C-Met, a ductal cell marker, was increased in cells treated with ROCK inhibitor. This modified culture condition may serve as an easy and convenient tool for culturing primary salivary gland cells for their application in hyposalivation therapy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | CHURCHILL LIVINGSTONE | - |
dc.subject | ACINAR-CELLS | - |
dc.subject | NECK RADIOTHERAPY | - |
dc.subject | GROWTH | - |
dc.subject | MIGRATION | - |
dc.subject | THERAPY | - |
dc.subject | HEAD | - |
dc.title | Rho-associated kinase inhibitor enhances the culture condition of isolated mouse salivary gland cells in vitro | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong-Hoon | - |
dc.identifier.doi | 10.1016/j.tice.2018.07.002 | - |
dc.identifier.scopusid | 2-s2.0-85050562328 | - |
dc.identifier.wosid | 000446691200003 | - |
dc.identifier.bibliographicCitation | TISSUE & CELL, v.54, pp.20 - 25 | - |
dc.relation.isPartOf | TISSUE & CELL | - |
dc.citation.title | TISSUE & CELL | - |
dc.citation.volume | 54 | - |
dc.citation.startPage | 20 | - |
dc.citation.endPage | 25 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Anatomy & Morphology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Anatomy & Morphology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | ACINAR-CELLS | - |
dc.subject.keywordPlus | NECK RADIOTHERAPY | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | HEAD | - |
dc.subject.keywordAuthor | ROCK inhibitor | - |
dc.subject.keywordAuthor | Y-27632 | - |
dc.subject.keywordAuthor | Hyposalivation | - |
dc.subject.keywordAuthor | Submandibular salivary gland | - |
dc.subject.keywordAuthor | Ductal cells | - |
dc.subject.keywordAuthor | Primary cell culture | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.